Use of antagoniststo the nuclear receptor alone or in combination with antagonists of the mineralocorticoid/alderstone receptor alone or in combination with antagonists of oestrogen receptor as antiviral therapeutic agents to prevent hemorrhaging and macrophage inflammatory effect of filovirus infection and to inhibit all filovirus replication in a patient

摘要

The therapeutic use of a combination of antagonists to the (1) mineralocorticoid/aldosterone receptor and the (2) oestrogen receptor and the (3) progesterone receptor and the (4) glucocorticoid receptor and (5) integrin receptor and (6) androgen receptor for their previously unappreciated, prophylactic and synergistic therapeutic properties as combination antivirals to inhibit filivirus replication